Pub. Date : 2015
PMID : 26551233
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency. | ferric citrate | fibroblast growth factor 23 | Homo sapiens |
| 2 | CONCLUSIONS: Oral FCH administration decreased serum intact FGF23 and C-term FGF23 levels and increased intact PTH levels; phosphate and 1,25(OH)2D levels were unchanged. | ferric citrate | fibroblast growth factor 23 | Homo sapiens |
| 3 | CONCLUSIONS: Oral FCH administration decreased serum intact FGF23 and C-term FGF23 levels and increased intact PTH levels; phosphate and 1,25(OH)2D levels were unchanged. | ferric citrate | fibroblast growth factor 23 | Homo sapiens |
| 4 | Oral FCH administration to treat iron deficiency is a possible strategy for reducing serum FGF23 levels independent of phosphate and VDRA. | ferric citrate | fibroblast growth factor 23 | Homo sapiens |